Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Coukos

Showing results (91-100 of 355) with videos related to

Pageof 36
Sort By:
The Journal of Biological Chemistry|May 25, 2017
<i>In silico</i> and cell-based analyses reveal strong divergence between prediction and observation of T-cell-recognized tumor antigen T-cell epitopesJulien Schmidt, Philippe Guillaume, Danijel Dojcinovic, et al.
Biochemical and Biophysical Research Communications|April 10, 2003
Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancerLin Zhang, Nuo Yang, Alisha Mohamed-Hadley, et al.
Current Opinion in Biotechnology|January 14, 2020
Biotechnologies to tackle the challenge of neoantigen identificationMarion Arnaud, Margaux Duchamp, Sara Bobisse, et al.
Drug Safety|January 17, 2019
Safety and Tolerability of Adoptive Cell Therapy in CancerBenita Wolf, Stefan Zimmermann, Caroline Arber, et al.
Journal for Immunotherapy of Cancer|October 24, 2018
A severe case of neuro-Sjögren's syndrome induced by pembrolizumabJaqueline Ghosn, Alex Vicino, Olivier Michielin, et al.
Current Opinion in Biotechnology|September 5, 2020
T-cell repertoire analysis and metrics of diversity and clonalityJohanna Chiffelle, Raphael Genolet, Marta As Perez, et al.
Gynecologic Oncology|November 2, 2011
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysisWei-Ting Hwang, Sarah F Adams, Emin Tahirovic, et al.
NPJ Systems Biology and Applications|July 21, 2017
Identifying biological mechanisms for favorable cancer prognosis using non-hypothesis-driven iterative survival analysisIsaac Crespo, Lou Götz, Robin Liechti, et al.
Expert Opinion on Biological Therapy|August 27, 2005
Immunotherapy for gynaecological malignanciesGeorge Coukos, Jose R Conejo-Garcia, Richard B S Roden, et al.
International Journal of Nanomedicine|May 3, 2014
Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancerEfthymia-Iliana Matthaiou, Jaleh Barar, Raphael Sandaltzopoulos, et al.
Pageof 36

Showing results (91-100 of 355) with videos related to

Sort By:
Pageof 36
The Journal of Biological Chemistry|May 25, 2017
<i>In silico</i> and cell-based analyses reveal strong divergence between prediction and observation of T-cell-recognized tumor antigen T-cell epitopesJulien Schmidt, Philippe Guillaume, Danijel Dojcinovic, et al.
Biochemical and Biophysical Research Communications|April 10, 2003
Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancerLin Zhang, Nuo Yang, Alisha Mohamed-Hadley, et al.
Current Opinion in Biotechnology|January 14, 2020
Biotechnologies to tackle the challenge of neoantigen identificationMarion Arnaud, Margaux Duchamp, Sara Bobisse, et al.
Drug Safety|January 17, 2019
Safety and Tolerability of Adoptive Cell Therapy in CancerBenita Wolf, Stefan Zimmermann, Caroline Arber, et al.
Journal for Immunotherapy of Cancer|October 24, 2018
A severe case of neuro-Sjögren's syndrome induced by pembrolizumabJaqueline Ghosn, Alex Vicino, Olivier Michielin, et al.
Current Opinion in Biotechnology|September 5, 2020
T-cell repertoire analysis and metrics of diversity and clonalityJohanna Chiffelle, Raphael Genolet, Marta As Perez, et al.
Gynecologic Oncology|November 2, 2011
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysisWei-Ting Hwang, Sarah F Adams, Emin Tahirovic, et al.
NPJ Systems Biology and Applications|July 21, 2017
Identifying biological mechanisms for favorable cancer prognosis using non-hypothesis-driven iterative survival analysisIsaac Crespo, Lou Götz, Robin Liechti, et al.
Expert Opinion on Biological Therapy|August 27, 2005
Immunotherapy for gynaecological malignanciesGeorge Coukos, Jose R Conejo-Garcia, Richard B S Roden, et al.
International Journal of Nanomedicine|May 3, 2014
Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancerEfthymia-Iliana Matthaiou, Jaleh Barar, Raphael Sandaltzopoulos, et al.
Pageof 36